Previous Grant Recipients

Previous Grant Recipients

Research Grant Awards

  • Myotonic Dystrophy Foundation: Support for research capacity development and advocacy support 2015-2017
  • Stanford University, Primary Investigator John Day, M.D., Ph.D.: Myotonic Dystrophy Clinical Research Network Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1
  • University of Utah, Primary Investigator Nicholas Johnson, M.D.: Myotonic Dystrophy Clinical Research Network Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1
  • Ohio State University, Primary Investigator John Kissel, M.D.: Myotonic Dystrophy Clinical Research Network Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1
  • University of Kansas Medical Center, Primary Investigator Jeffrey Statland, M.D.: Myotonic Dystrophy Clinical Research Network Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1
  • University of Florida, Primary Investigator S.H. Siubramony, M.D.: Myotonic Dystrophy Clinical Research Network Multicenter Study of Natural History and Genetic Modifiers in Myotonic Dystrophy Type 1
  • European Neuromuscular Centre, Primary Investigator Alexandra Breukel, Ph.D., Workshop Support - Myotonic Dystrophy - Developing a European Consortium for Care and Therapy
  • University of Utah, Primary Investigator Nicholas Johnson, M.D.: Phase I Development and Validation of Screening Technology for Myotonic Dystrophy Population-Based Prevalence Study

Fellowship Awards

  • Viachaslau Bernat, Ph.D., The Scripps Research Institute - Florida, US: Precise Lead Therapeutics for Myotonic Dystrophy via in cellulo Synthesis
  • Ian DeVolder, Ph.D., University of Iowa, U.S.: Structural and Functional Connectivity in the Brains of Patients with Adult and Late Onset Myotonic Dystrophy Type 1 (DM1) - A Potential Biomarker for Disease Progression
  • Melissa M. Dixon, Ph.D., University of Utah, U.S.: Evaluation of Functional Connectivity as a Brain Biomarker in Congenital Myotonic Dystrophy
  • Benjamin Gallais, Ph.D., Universite de Sherbrooke, Canada: A 14-Year Longitudinal Study of Cognition and Central Nervous System Involvement in Adult and Late-Onset Phenotypes of Myotonic Dystrophy Type 1
  • Ginny R. Morriss, Ph.D., Baylor University, U.S.: Mechanisms of Skeletal Muscle Wasting Caused by Expanded CUG Repeat RNA
  • Laura Valentina Renna, Ph.D.,  IRCCS-Policlinico San Donato, Italy: A New Approach of Pathomolecular Mechanisms in Myotonic Dystrophy Insulin Resistance by Nutrigenomics
  • Lukasz Sznajder, Ph.D., University of Florida, U.S.: Myotonic Dystrophy Type 2 - Mouse Models, Pathomechanism and Therapy
  • Ranjan Batra, Ph.D., University of California San Diego, U.S.: Studying Genome-Wide MBNL-RNA Structure Interactions in Neuronal Development and Myotonic Dystrophy
  • Melissa Hinman, Ph.D., University of Oregon, U.S.: An Investigation of the Cellular and Microbial Etiologies of Gastrointestinal Pathologies in Myotonic Dystrophy Using the Zebrafish

Improving the quality of life of people living with myotonic dystrophy through funding for basic and translational research efforts and patient advocacy.